• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates
Home » FDA clears Biomet’s hip implant | Regulatory roundup

FDA clears Biomet’s hip implant | Regulatory roundup

April 27, 2011 By MassDevice staff

Clearances roundup

Biomet Inc. received FDA 510(k) clearance for its new hip replacement device.

Warsaw, Ind.-based company said its Active Articulation E1 dual mobility hip system is an implant option for orthopedic surgeons performing hip replacement surgery.

The "dual mobility" design "utilizes a small femoral head that articulates within polyethylene. The large polyethylene bearing, when triggered, acts as a large head bearing that articulates within a metal cup," according to the company.

"The [system] provides an excellent combination of wear resistance and implant stability," Biomet U.S. orthopedics division president Jon Serbousek said in prepared remarks.

The company is competing against the likes of Stryker Corp. (NYSE:SYK) and Zimmer Holdings Inc. (NYSE:ZHM), whose hip implants orthopedic surgeons gave high marks to in a recent survey.

Biomet reported losses of $11.6 million on sales of $678.0 million during the three months ended Feb. 28 — the company’s third quarter. That compares with losses $3.1 million on sales of $669.8 million during the same period ending February 28, 2010.

Here’s a roundup of companies announcing clearances and approvals from the Food & Drug Administration and foreign regulatory agencies. Check out MassDevice’s compilation of the latest regulatory news for additional clearances and approvals.

  • K2M wins 510(k) for Everest spinal system
    K2M Inc. received 510(k) clearance from the FDA to market the EVEREST Degenerative Spinal System, a versatile top-loading polyaxial pedicle screw system featuring the ability to accommodate multiple levels of fixation rigidity to help surgeons individualize patient care. The system provides for both titanium and cobalt chrome rods of two different diameters, 5.5 and 6.0 mm, limiting inventory and increasing adaptability.
    Read more
  • Biotronik lands FDA approval for Evia pacemaker portfolio expansion
    BIOTRONIK announced FDA approval of the new Estella and Effecta pacemakers, as well as advanced new features and technologies for the Evia pacemaker family.
    Read more
  • Acousticon wins FDA clearance for hearing aid tech
    A new all-in-one hearing aid fitting system received 510(k) clearance. Acousticon, the Durham, N.C.-based American subsidiary of German firm Acousticon GmbH, announced that the FDA cleared its ACAM-5 system. ACAM-5 combines hardware and software into a system that helps audiologists understand the severity of a patient’s hearing loss and optimize the fit of a hearing aid to the hearing needs of each patient, reports MedCity News.
    Read more
  • Sound Surgical wins FDA clearance for fat removal system
    Sound Surgical Technologies announced that the PowerX Lipo System has been cleared for use by the FDA. A new power-assisted liposuction device, the PowerX System combines a rotational handpiece and multiple user settings to allow physicians to utilize the system for different body contouring applications – from gentle, superficial work to more aggressive, large volume fat removal.
    Read more
  • FDA approves updated indication for Si-Bone’s iFuse implant
    SI-BONE Inc., a medical device company that is pioneering the use of a minimally invasive surgical (MIS) device to treat the sacroiliac (SI) joint announced the FDA approved a major modification to the existing product label. The Approval targets the use of iFuse Implant System for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis. FDA-OSDB worked with SI-BONE Inc. to arrive at a more accurate description of the intended use of the iFuse System, the company said.
    Read more
  • Varian wins Chinese approval for image-guided cancer treatment system
    Varian Medical Systems Inc. (NYSE:VAR) announced that the Chinese State Food and Drug Administration (SFDA) has approved its TrueBeam system for image-guided radiotherapy. TrueBeam is a fully-integrated system designed from the ground up to treat tumors with great speed and accuracy — including tumors that move during treatment as the patient breathes in and out.
    Read more
  • VeraLight wins Health Canada licence approval for diabetes screening device
    VeraLight Inc. announced its Scout DS device was granted a Health Canada Medical Device Licence for non-invasive diabetes screening. The device needs no blood and does not require fasting. The patient simply places their forearm onto the portable table-top unit and a quantitative result is reported in about three minutes.
    Read more
  • MedShape wins CE Mark certification for soft tissue fixation devices
    MedShape Solutions Inc., the industry leader in innovative shape memory orthopedic devices, announced that it has been notified of CE Mark approval for the Morphix Anchor and the ExoShape Interference Fixation Device. The company has begun discussions with third party distributors across the region.
    Read more
  • Reverse Medical wins 510(k) clearance for distal intracranial catheter
    Reverse Medical Corp. received FDA 510(k) clearance to market the ReFlex line of intracranial catheters for distal neurovascular access and microcatheter therapeutic delivery. The ReFlex Catheter is uniquely designed to provide endovascular intracranial access during interventional neurovascular procedures.
    Read more
  • Guided Therapeutics FDA meeting on PMA for cervical cancer test "productive"
    Guided Therapeutics Inc. (OTC:GTHP), announced that it held a productive meeting with FDA officials to review the company’s pre-market approval application (PMA) for its non-invasive test for the early detection of cervical pre-cancer. During the meeting with FDA reviewers, which was requested by Guided Therapeutics, company representatives outlined proposed responses to recent FDA questions regarding the PMA application and also held discussions regarding proposed claims for use for the technology.
    Read more
  • Japanese firm’s Alzheimer’s skin patch falls short of FDA approval
    Eisai Co. Ltd. (TYO:4523) announced that its partner Teikoku Pharma USA Inc. received a Complete Response Letter from the FDA concerning the New Drug Application (NDA) it submitted for a transdermal patch formulation of Aricept (donepezil hydrochloride). The FDA issues a Complete Response Letter to indicate the review cycle of an application is complete and there are still requirements to be fulfilled. The requirements of FDA are mainly formulation and usage Eisai and Teikoku USA will work with FDA to assess the Complete Response Letter and determine next steps.
    Read more

Filed Under: 510(k), News Well, Pre-Market Approval (PMA) Tagged With: Biomet, Biotronik, Guided Therapeutics Inc., MedShape Solutions Inc., Reverse Medical Corp., SiBone, Varian Medical Systems, VeraLight Inc.

In case you missed it

  • Leading Medical UX Trends
  • Ex-Acclarent execs fined $1.5M in off-label marketing case
  • CDER head Woodcock to lead FDA for now
  • Prosecutors want to present evidence of Elizabeth Holmes’ quest for wealth and fame
  • TransEnterix raises more than $31M in stock offering
  • Boston Scientific launches WaveWriter Alpha spinal cord stim
  • What’s next for the FDA and for Stephen Hahn?
  • Apple magnetic charger, smartwatch may deactivate Medtronic ICD
  • Medicare to cover breakthrough devices
  • FDA debuts plan for AI-based Software as a Medical Device
  • EU allows remote audits for medical devices during pandemic
  • Smith+Nephew sees Movemedical automating inventory for its sales people
  • BD stock up on Street-beating preliminary quarterly revenue numbers
  • Boston Scientific’s preliminary Q4 results show 6.8% revenue decline
  • BREAKING: Steris to acquire Cantel Medical in $4.6B deal
  • FDA grants EUA for RapCov rapid COVID-19 antibody test
  • Former Corindus CEO Toland joins robotic `micro’ surgical startup

RSS From Medical Design & Outsourcing

  • Reflow Medical launches low-profile reinforced support catheters
    Reflow Medical today announced it has launched its Reflow Spex Low Profile reinforced support catheters. The Spex LP catheters are designed to provide the lowest profile tip to access and cross the tightest and most complex lesions with a supportive system. They come in 0.014 in. and 0.018 in. sizes and can be combined with… […]
  • CDER head Woodcock to lead FDA for now
    FDA veteran Dr. Janet Woodcock has been tapped as interim FDA commissioner by the Biden administration, according to published reports. An article by BioCentury also said that former FDA commissioner David Kessler, who had been mentioned as a possible replacement for current commissioner Stephen Hahn, will be a consultant to the agency but will not… […]
  • What’s next for the FDA and for Stephen Hahn?
    Outgoing FDA commissioner Stephen Hahn says he needs some time to reflect on his future after leading the FDA for a little over a year. It’s hard to blame him. Hahn’s brief tenure at FDA has been rocky, to say the least. (News of his temporary replacement broke on Thursday, when the incoming Biden administration… […]
  • Medicare to cover breakthrough devices
    FDA-designated breakthrough devices will have Medicare coverage the same day they are approved, under a final rule issued this week by the Centers for Medicare and Medicaid Services (CMS). The Medicare Coverage of Innovative Technology (MCIT) rule will provide national Medicare coverage as early as the same day as FDA market authorization for breakthrough devices… […]
  • FDA debuts plan for AI-based Software as a Medical Device
    The FDA today released its first plan to regulate artificial intelligence/machine learning (AI/ML)-based Software as a Medical Device (SaMD). The plan is a response to feedback received from the agency’s April 2019 discussion paper, “Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning-Based Software as a Medical Device.” It outlines five actions that the FDA… […]
  • EU allows remote audits for medical devices during pandemic
    The European Union has announced that it will temporarily allow remote audits of medical devices and in vitro diagnostics under the new regulations (MDR IVDR), set to go into effect on May 2021 and 2022 respectively. In a document published Monday, the European Commission agreed with industry and notified bodies that the ongoing COVID-19 pandemic… […]
  • Apple magnetic charger, smartwatch may deactivate Medtronic ICD
    A new study in the Heart Rhythm Journal showed a magnetic charger for the iPhone 12 was able to deactivate a Medtronic implantable cardioverter defibrillator (ICD). The iPhone 12 has a circular array of magnets deployed around a central charging coil, making it compatible with the company’s wireless “MagSafe” accessories, according to the study published… […]
  • BREAKING: Steris to acquire Cantel Medical in $4.6B deal
    Steris (NYSE:STE) announced today that it will acquire Cantel Medical (NYSE:CMD) for $4.6 billion — a major merger in the infection prevention space. The deal is expected to close by June 30, pending customary closing conditions, regulatory approvals and an OK by Cantel shareholders. News of the merger comes a month and a half after Steris closed… […]
  • How Abbott stayed two steps ahead of COVID-19
    Developing a fast COVID-19 that resembled a pregnancy test and building two factories to boost productions — those were but two of the quick-thinking actions that Abbott (NYSE:ABT) officials took in the early months of a deadly coronavirus pandemic. Abbott began tracking the virus in China at the end of 2019 and into early 2020. By February,… […]
  • BREAKING: Big medtech suspends political contributions in wake of Electoral College vote
    Just as they lined up to condemn last week’s attack on the U.S. Capitol, major medtech companies are suspending political contributions because of 147 federal lawmakers’ refusal to acknowledge the Electoral College win by President-elect Joe Biden and Vice President-elect Kamala Harris. Boston Scientific announced on Sunday that it has chosen to temporarily suspend its… […]
  • Neurofeedback could help prostheses feel lighter: Here’s how
    Researchers at ETH Zurich have developed a prosthesis system that connects to the body’s nervous system to help amputees perceive a prosthetic weight as lower. The prosthesis system provides feedback to the wearer using electrodes implanted in the thigh that are connected to the leg nerves. Information from the tactile sensors under the sole of… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS